The Amyotrophic Lateral Sclerosis Treatment Market is gaining momentum globally as the prevalence of this rare but devastating neurological disorder increases. Valued at USD 674.90 million in 2024, the market is projected to grow at a CAGR of 6.30% between 2025 and 2032. While amyotrophic lateral sclerosis (ALS) remains incurable, advances in drug development, gene therapy, and palliative care...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek